Literature DB >> 1660488

An immunoassay for specific amplified HCV sequences.

L Imberti1, E Cariani, A Bettinardi, A Zonaro, A Albertini, D Primi.   

Abstract

The direct detection of viraemia could improve greatly the efficacy of presently available assays. Due to its sensitivity, the polymerase chain reaction represents the method of choice for direct detection of viral nucleic acid. However, the clinical application of this method is hampered by the requirement of hybridization with radioactively labelled probes. In this study we demonstrate that HCV cDNA, amplified by the polymerase chain reaction from both liver tissues and sera, can be detected specifically by a new non-radioisotopic method, DNA enzyme immunoassay, that is based on an antibody that selectively recognizes double, but not single-stranded DNA. The assay reveals the hybridization events, independently from the DNA sequences, and therefore can be used with any combination of primers and probes. Most importantly, the method has a conventional ELISA format and is compatible with standard facilities of clinical laboratories. The availability of this new approach for revealing amplified sequences may facilitate greatly the use of PCR as the method of choice for early diagnosis of HCV infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660488     DOI: 10.1016/0166-0934(91)90103-7

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  23 in total

1.  Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.

Authors:  Jean-Christophe Plantier; Laurence Vergne; Florence Damond; Souleymane MBoup; Eitel MPoudi-NGole; Laurence Buzelay; Isabelle Farfara; Denys Brand; Martine Peeters; Françoise Brun-Vézinet; Eric Delaporte; Francis Barin
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection -- a prospective cross-sectional study.

Authors:  Golo Ahlenstiel; Agathe Iwan; Jacob Nattermann; Karin Bueren; Jurgen K Rockstroh; Hans H Brackmann; Bernd Kupfer; Olfert Landt; Amnon Peled; Tilman Sauerbruch; Ulrich Spengler; Rainer P Woitas
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

3.  Sexual behaviour and multiple infections in drug abusers.

Authors:  R C Coppola; G Masia; M L di Martino; G Carboni; E Muggianu; R Piro; P E Manconi
Journal:  Eur J Epidemiol       Date:  1996-10       Impact factor: 8.082

4.  Hepatitis C viraemia and antibody to core epitopes in anti-HCV ELISA negative blood donors.

Authors:  P Ferroni; V Gasparini; M Zaninetti; D Colzani; G Mascolo
Journal:  Eur J Epidemiol       Date:  1994-10       Impact factor: 8.082

5.  Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease.

Authors:  M Pirisi; P Ferroni; C Fabris; P Toniutto; G Soardo; D Vitulli; V Gasparini; E Bartoli
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

6.  HCV transmission in family members of subjects with HCV related chronic liver disease.

Authors:  L Demelia; E Vallebona; R Poma; G Sanna; G Masia; R C Coppola
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

7.  Role of hepatitis C virus in chronic liver disease occurring after orthotopic liver transplantation.

Authors:  M Pastore; M Willems; C Cornu; J P Buts; R Reding; J de Ville de Goyet; J Rahier; J B Otte; S H Yap; E M Sokal
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

8.  HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis C.

Authors:  P Fabris; M R Biasin; D Infantolino; L Romanó; P Benedetti; G Tositti; G P Pellizzer; A R Zanetti; C Stecca; G Marchelle; F de Lalla
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

9.  Differential expansion of T-cell receptor variable beta subsets after antigenic stimulation in patients with different outcomes of hepatitis C infection.

Authors:  Rainer P Woitas; Martin Sippel; Eva-Maria Althausen; Hans H Brackmann; Bettina Kochan; Bertfried Matz; Jürgen K Rockstroh; Tilman Sauerbruch; Ulrich Spengler
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

10.  Quantification of hepatitis C virus RNA by competitive amplification of RNA from denatured serum and hybridization on microtiter plates.

Authors:  A Ravaggi; A Zonaro; C Mazza; A Albertini; E Cariani
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.